Source 1primary paper2026MED
Toolkit/logic-gated CAR designs
logic-gated CAR designs
Also known as: logic-gated CAR
Taxonomy: Mechanism Branch / Architecture. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
Key developments include multi-antigen and logic-gated CAR designs to mitigate tumor immune evasion.
Usefulness & Problems
Why this is useful
Logic-gated CAR designs are described as next-generation CAR-T engineering strategies for glioblastoma. The abstract states they are intended to mitigate tumor immune evasion.; mitigating tumor immune evasion in glioblastoma CAR-T therapy
Source:
Logic-gated CAR designs are described as next-generation CAR-T engineering strategies for glioblastoma. The abstract states they are intended to mitigate tumor immune evasion.
Source:
mitigating tumor immune evasion in glioblastoma CAR-T therapy
Problem solved
The review links logic-gated CAR designs to overcoming immune evasion in GBM, where antigenic escape and heterogeneity are major barriers.; addresses antigenic escape and heterogeneous antigen expression
Source:
The review links logic-gated CAR designs to overcoming immune evasion in GBM, where antigenic escape and heterogeneity are major barriers.
Source:
addresses antigenic escape and heterogeneous antigen expression
Problem links
addresses antigenic escape and heterogeneous antigen expression
LiteratureThe review links logic-gated CAR designs to overcoming immune evasion in GBM, where antigenic escape and heterogeneity are major barriers.
Source:
The review links logic-gated CAR designs to overcoming immune evasion in GBM, where antigenic escape and heterogeneity are major barriers.
Taxonomy & Function
Primary hierarchy
Mechanism Branch
Architecture: A composed arrangement of multiple parts that instantiates one or more mechanisms.
Techniques
Computational DesignTarget processes
translationImplementation Constraints
cofactor dependency: cofactor requirement unknownencoding mode: genetically encodedimplementation constraint: context specific validationimplementation constraint: multi component delivery burdenoperating role: regulatorswitch architecture: multi component
Operational role: regulator. Architecture cues: multi component. Implementation mode: genetically encoded. Cofactor status: cofactor requirement unknown.
Uses more than one coordinated component. Independent follow-up evidence is still limited. Validation breadth across biological contexts is still narrow. Independent reuse still looks limited, so the evidence base may be fragile. Multi-component delivery and stoichiometry control can make deployment harder. No canonical validation observations are stored yet, so context-specific performance remains under-specified.
Validation
Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication
Supporting Sources
Ranked Claims
In glioblastoma, intratumoral heterogeneity, antigenic escape, an immunosuppressive tumor microenvironment, and blood-brain barrier constraints limit CAR-T cell trafficking, persistence, and sustained antitumor activity in the central nervous system.
Successful translation of CAR-T cell therapy to solid tumors remains a major unmet clinical challenge.
Armored CAR-T cells can be engineered for cytokine delivery or resistance to suppressive mediators such as TGF-β in glioblastoma.
Multi-antigen and logic-gated CAR designs are being developed to mitigate tumor immune evasion in glioblastoma.
Approval Evidence
1 source3 linked approval claimsfirst-pass slug logic-gated-car-designs
Key developments include multi-antigen and logic-gated CAR designs to mitigate tumor immune evasion.
Source:
barrier statementsupports
In glioblastoma, intratumoral heterogeneity, antigenic escape, an immunosuppressive tumor microenvironment, and blood-brain barrier constraints limit CAR-T cell trafficking, persistence, and sustained antitumor activity in the central nervous system.
Source:
challenge statementsupports
Successful translation of CAR-T cell therapy to solid tumors remains a major unmet clinical challenge.
Source:
engineering strategysupports
Multi-antigen and logic-gated CAR designs are being developed to mitigate tumor immune evasion in glioblastoma.
Source:
Comparisons
Source-stated alternatives
The abstract contrasts logic-gated CAR designs with armored CAR-T cells, checkpoint-resistant constructs, and combinatorial treatment strategies.
Source:
The abstract contrasts logic-gated CAR designs with armored CAR-T cells, checkpoint-resistant constructs, and combinatorial treatment strategies.
Source-backed strengths
presented as a next-generation engineering strategy for GBM
Source:
presented as a next-generation engineering strategy for GBM
Compared with armored CAR-T cells
The abstract contrasts logic-gated CAR designs with armored CAR-T cells, checkpoint-resistant constructs, and combinatorial treatment strategies.
Shared frame: source-stated alternative in extracted literature
Strengths here: presented as a next-generation engineering strategy for GBM.
Source:
The abstract contrasts logic-gated CAR designs with armored CAR-T cells, checkpoint-resistant constructs, and combinatorial treatment strategies.
Compared with CAR-T
The abstract contrasts logic-gated CAR designs with armored CAR-T cells, checkpoint-resistant constructs, and combinatorial treatment strategies.
Shared frame: source-stated alternative in extracted literature
Strengths here: presented as a next-generation engineering strategy for GBM.
Source:
The abstract contrasts logic-gated CAR designs with armored CAR-T cells, checkpoint-resistant constructs, and combinatorial treatment strategies.
Compared with CAR-T cells
The abstract contrasts logic-gated CAR designs with armored CAR-T cells, checkpoint-resistant constructs, and combinatorial treatment strategies.
Shared frame: source-stated alternative in extracted literature
Strengths here: presented as a next-generation engineering strategy for GBM.
Source:
The abstract contrasts logic-gated CAR designs with armored CAR-T cells, checkpoint-resistant constructs, and combinatorial treatment strategies.
Compared with CAR-T cell therapy
The abstract contrasts logic-gated CAR designs with armored CAR-T cells, checkpoint-resistant constructs, and combinatorial treatment strategies.
Shared frame: source-stated alternative in extracted literature
Strengths here: presented as a next-generation engineering strategy for GBM.
Source:
The abstract contrasts logic-gated CAR designs with armored CAR-T cells, checkpoint-resistant constructs, and combinatorial treatment strategies.
Compared with CAR-T therapy
The abstract contrasts logic-gated CAR designs with armored CAR-T cells, checkpoint-resistant constructs, and combinatorial treatment strategies.
Shared frame: source-stated alternative in extracted literature
Strengths here: presented as a next-generation engineering strategy for GBM.
Source:
The abstract contrasts logic-gated CAR designs with armored CAR-T cells, checkpoint-resistant constructs, and combinatorial treatment strategies.
Compared with Chimeric Antigen Receptor (CAR) T-cell therapy
The abstract contrasts logic-gated CAR designs with armored CAR-T cells, checkpoint-resistant constructs, and combinatorial treatment strategies.
Shared frame: source-stated alternative in extracted literature
Strengths here: presented as a next-generation engineering strategy for GBM.
Source:
The abstract contrasts logic-gated CAR designs with armored CAR-T cells, checkpoint-resistant constructs, and combinatorial treatment strategies.
Compared with chimeric antigen receptor T cells
The abstract contrasts logic-gated CAR designs with armored CAR-T cells, checkpoint-resistant constructs, and combinatorial treatment strategies.
Shared frame: source-stated alternative in extracted literature
Strengths here: presented as a next-generation engineering strategy for GBM.
Source:
The abstract contrasts logic-gated CAR designs with armored CAR-T cells, checkpoint-resistant constructs, and combinatorial treatment strategies.
Compared with Chimeric antigen receptor T-cell therapy
The abstract contrasts logic-gated CAR designs with armored CAR-T cells, checkpoint-resistant constructs, and combinatorial treatment strategies.
Shared frame: source-stated alternative in extracted literature
Strengths here: presented as a next-generation engineering strategy for GBM.
Source:
The abstract contrasts logic-gated CAR designs with armored CAR-T cells, checkpoint-resistant constructs, and combinatorial treatment strategies.
Ranked Citations
- 1.